Navigation Links
ReachMD XM 157 Announces Medical Information Feature on Treatment Options for Management of Hyponatremia
Date:10/27/2008

pproaches of treatment relevant to them."

About Vaprisol: Discovered and developed by Astellas Pharma Inc. headquartered in Tokyo, Japan, Vaprisol is a drug that blocks the activity of AVP, resulting in increased urine output without loss of valuable electrolytes such as sodium and potassium. This effect, known as "aquaresis," helps to increase serum sodium levels in patients with hyponatremia. Vaprisol is the first AVP receptor antagonist with a demonstrated safety profile and that effectively promotes aquaresis in order to help restore salt and water balance in patients with euvolemic and hypervolemic hyponatremia.

Vaprisol is indicated for the treatment of euvolemic and hypervolemic hyponatremia in hospitalized patients. Vaprisol is not indicated for the treatment of congestive heart failure. It should only be used for the treatment of hyponatremia in patients with underlying heart failure when the expected benefit of raising serum sodium outweighs the increased risk of adverse events. Vaprisol is contraindicated in patients with hypovolemic hyponatremia. In addition, coadministration of Vaprisol with potent CYP3A4 inhibitors, such as ketoconazole, itraconazole, clarithromycin, ritanovir, and indinavir, is contraindicated. Serum sodium, volume, and neurological status must be monitored frequently because Vaprisol potentially can cause overly rapid correction of sodium leading to serious sequelae. The use of Vaprisol in patients with hepatic impairment (including ascites, cirrhosis, or portal hypertension) or renal impairment has not been systematically evaluated. Use caution when administering Vaprisol to these patients. The most common adverse reactions reported were infusion site reactions (incidence of 73% and 63% for 20 mg/day and 40 mg/day respectively) which were also the most common type of adverse reaction leading to discontinuation of Vaprisol. Discontinuations from treatment due to infusion site reactions were more common among Vaprisol-tr
'/>"/>

SOURCE ReachMD XM 157
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. ReachMD XM 157 to Present Stand Up To Cancer Special as the Only Live Simulcast on XM Satellite Radio for Health Care Professionals
2. ReachMD, LLC Announces New Strategic Partnership With The American Medical Student Association
3. ReachMD XM 157 Announces Medical Information Feature on Irritable Bowel Syndrome, Its Treatments, and the Role of Probiotics
4. The United States Army Medical Department Announces the Launch of an Innovative New Programming Series Called The Strength to Heal That Will Run on ReachMD XM 157 - The Channel for Medical Professionals on XM Radio.
5. ReachMD Launches New Series on GI Issues
6. AMA Foundation and ReachMD Collaborate to Broadcast Excellence in Medicine Awards
7. ReachMD and VerusMed Broadcast Medical Conference Coverage on XM Satellite Radio
8. Memory Pharmaceuticals Announces Issuance of Key U.S. Patent for R3487/MEM 3454 and R4996/MEM 63908
9. UCSF Chancellor J. Michael Bishop Announces Plan To Step Down
10. USC Cancer Center Announces Contribution By Larry and Judy Freeman
11. Sikorsky Aircraft Announces Contract with Boston MedFlight for S-76C++(TM) Helicopter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 25, 2014 AlignLife of Wauwatosa ... afford certain items. During the holiday season, AlignLife looks forward ... 70 toys," says Dr. Sara Mahalko-Leonhardt, owner of AlignLife. "It ... joy, knowing that we are able to give kids toys ... not been for the generosity of our patients." , The ...
(Date:12/24/2014)... Epigenetics finds applications in a large number of ... developmental biology, and research for metabolic and genetic disorders. ... widely used techniques for the discovery and development of ... is rapidly growing worldwide. In 2012, there were 14.1 ... 32.6 million people living with cancer (within five years ...
(Date:12/24/2014)... 25, 2014 Recently, iFitDress.com, a famous dress ... prom dresses under $150 . All these items are brand ... website has already been updated with the new range of ... ordered so far. All iFitDress.com’s designs are made according to ... using great materials. Every outfit from the company is handpicked ...
(Date:12/24/2014)... December 24, 2014 New studies reveal that ... hearing loss related depression (March 6, 2014, JAMA Otolaryngology*). And ... hearing loss (about 50 percent according to recent polls) facing ... on how a person feels and relates to the world. ... improvements are also made by way of:, , ...
(Date:12/24/2014)... 2014 The federal court overseeing ... blood thinner caused life-threatening episodes of internal bleeding ... for the proceeding, Bernstein Liebhard LLP reports. According ... plans to select lawyers to serve as Liaison ... appointing a Plaintiffs’ Steering Committee, which will coordinate ...
Breaking Medicine News(10 mins):Health News:AlignLife of Wauwatosa Brings Joy to Less Fortunate Families 2Health News:Global Epigenetics Market Was Valued at $413.24 Million in 2014 - New Research Report by MarketsandMarkets 2Health News:Global Epigenetics Market Was Valued at $413.24 Million in 2014 - New Research Report by MarketsandMarkets 3Health News:Many Prom Dresses under 150 from Well-known Dress Manufacturer iFitDress.com 2Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 2Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 3Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 4Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 5Health News:Recent Studys Underscore the Fact That One of the Best Gifts to Give This Holiday Season is a Hearing Test 6Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 3
... in developing a computer aided alert program that can predict ... attempts made to prevent the disease before and the current ... researchers are of the opinion that such a prediction may ... hospitalized patients. ,Deep-vein thrombosis or the formation of ...
... offered to patients with heart attack calm disease progression but ... are totipotent, may be a potential source for regeneration of ... a promising future in this regard. , This has ... stem cells are an emerging source for treatment of diseased ...
... conducted in Spain has focused on the increasing incidence ... be associated with an increased risk of cancer in ... has been proven to have disastrous effects on the ... obstetric complications such as extra uterine pregnancy, or pregnancy ...
... antihypertensive strategies that use calcium channel blockers and ... with beta-blockers and diuretics. ,Hypertensive patients either ... without the ACE inhibitor perindopril or the beta-blocker ... ,The trial ran for five years, but it ...
... shows people suffering from the bone-thinning disease osteoporosis may ... //, a condition in which people have a difficult ... can markedly improve bone mineral density, or BMD, among ... tend to have thinning bones, but little study exists ...
... in Journal of Dental Research, caries in primary teeth may ... tooth can have caries for a wide variety of reasons ... of exposure to water fluoridation, disturbance to primary teeth, and ... can caries in primary teeth have long-term effect on the ...
Cached Medicine News:
(Date:12/24/2014)... 24, 2014 LifeScienceIndustryResearch.com ... Disposable Syringe Industry of 178 pages providing ... intelligence library. The 2014 Market ... is a professional and deep research report ... analysis, the report introduces Disposable Syringe basic ...
(Date:12/24/2014)... , Dec. 23, 2014 Tianyin Pharmaceutical ... that specializes in patented biopharmaceutical, modernized traditional Chinese ... (API) today announced that the Company achieved the ... Manufacturing Practice (GMP) certificate of TPI,s Qionglai Facility ... (CFDA). The public notice period is a significant ...
(Date:12/22/2014)... Mass. , Dec. 22, 2014 ... leading manufacturer of innovative dialysis products, announced today ... has cleared its System One™ to perform hemodialysis ... known as home nocturnal hemodialysis. NxStage,s® System One ... by the FDA for this indication. ...
Breaking Medicine Technology:World Disposable Syringe Market 2014 Report: China and Regional Analysis 2World Disposable Syringe Market 2014 Report: China and Regional Analysis 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 4World Disposable Syringe Market 2014 Report: China and Regional Analysis 5TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3
... Biosystems and Berg Diagnostics, members of the Berg Pharma group ... Disorder (ASD) Biomarker Discovery Using the Berg Interrogative Biology ... in San Francisco, CA. The study was conducted by assessing ... where more than 1 child was afflicted by the disorder. ...
... ANN ARBOR, Mich., March 5, 2012  Neuroimaging for stroke patients ... nationwide for stroke care, according to University of Michigan research. ... found that 95 percent of stroke patients who received magnetic ... "Compared to CT, MRI is a more ...
Cached Medicine Technology:Berg Pharma Companies Present Groundbreaking Approach to Understanding Autism and Identify Novel Biomarkers That May be Crucial in Diagnosis 2Berg Pharma Companies Present Groundbreaking Approach to Understanding Autism and Identify Novel Biomarkers That May be Crucial in Diagnosis 3Physicians Order Costly, Redundant Neuroimaging for Stroke Patients, Study Says 2
... completely digital camera system by KARL STORZ, ... endoscopic camera systems. Digital Source Sampling technology, ... the fully digital transfer of information with ... converter, as well as loss-free data storage ...
... Countless challenges. One complete solution. ... documentation. Instrument maintenance. Staff turnover. These are ... point-of-care professionals challenges that can impact ... your critically-ill patients. , , ...
... The Dornier Medilas D Fibertom is a 60 ... nm wavelength. The use of Diode Power Bar ... system ideal for endovenous laser treatment for varicose ... Medilas D Fibertom also includes unique safety features ...
... is a new High Magnification Slit-Lamp Biomicroscope. ... anterior segment diagnostics and documentation This highly ... to maintain, and very cost effective. The ... Magnification Slit-Lamp Biomicroscope available today. It can ...
Medicine Products: